ClinicalTrials.gg
RecruitingNCT07349901Updated Mar 17, 2026

Predicting Hospital Readmission for Surgical Patients Using Deep Learning Models With Smart Watch and Smart Ring Sensors Data

An observational study in Patient Readmission, sponsored by Getúlio Vargas University Hospital. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Getúlio Vargas University Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Postoperative Complications with a site in Brazil — 8 open to participants now, 8 under way, none of them phase 3. Postoperative Complications · Brazil.

Planned enrollment
7th of 11
300 · median 362
Started
2026
with 2 others
Observational
11 of 36
4 open now
Registered
35th of 36
by date

Among the 36 studies in Postoperative Complications with a site in Brazil, this one is the 7th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2026, is one of 11 observational ones, and was the 35th registered.

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

8 of the 36 studies in Postoperative Complications with a site in Brazil are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Postoperative Complications with a site in Brazil, or all of them as a file.
02

Study summary

Hospital readmissions are an important measure of healthcare quality and safety. These events create a substantial burden for patients, families, and health systems because they may increase costs, extend recovery time, and lead to more serious postoperative complications. Predicting which patients are at higher risk of readmission remains difficult, as many complications begin silently and are not easily identified in routine clinical evaluations.

This study aims to evaluate whether artificial intelligence (AI) can help predict hospital readmissions in surgical patients by analyzing physiological and behavioral data collected before and after surgery. To achieve this, participants will use wearable devices-specifically a smartwatch and a smart ring-capable of continuously monitoring health biomarkers such as heart rate, electrocardiogram (ECG), oxygen saturation, sleep patterns, blood pressure trends, body composition through bioimpedance, and stress indicators. These devices are provided through a technology partnership and sponsorship from Samsung, which supports the study with advanced health technologies.

This is a prospective, single-center cohort study conducted at the main tertiary hospital in the state of Amazonas. Approximately 225 to 300 adults undergoing medium- or large-scale elective surgeries will be invited to participate over a 25-month period. All participants will provide informed consent. After enrollment, the study will collect demographic information, preoperative assessments, validated sleep questionnaires, comorbidity indexes such as the Charlson Comorbidity Index, laboratory exams, pulmonary function tests, intraoperative and postoperative data, and hospital discharge information.

Participants will be continuously monitored using wearable devices during their hospital stay-including the first 48 hours in the intensive care unit when applicable-and for 30 days after hospital discharge. These physiological data will be integrated with clinical and laboratory information to create a comprehensive dataset.

The primary objective is to develop and test artificial intelligence models capable of predicting 30-day hospital readmission following elective surgery. Both deep learning approaches and classical machine-learning techniques will be evaluated. By analyzing large volumes of continuous physiologic data, these models may identify early signs of postoperative deterioration that would otherwise go unnoticed.

If successful, this study may improve postoperative care, support earlier clinical intervention, reduce complications, and help healthcare teams provide safer recovery pathways for surgical patients.

Read the detailed description

Hospital readmissions are well established as key indicators of healthcare quality, particularly in the postoperative setting. Unplanned readmissions often reflect complications that were not fully predicted or adequately managed, generating substantial financial and clinical burden for health systems. In the United States, 3.8 million adult readmissions occurred within 30 days in 2018, with an average cost of US$15,200 per event. In Brazil, similarly high readmission rates have been reported, with 13.4% of more than 22,000 hospitalizations resulting in return visits, largely due to hospital infection, obstructive sleep apnea, and cardiac arrhythmias. Sleep disturbances-including obstructive sleep apnea-are among the most significant contributors to postoperative complications and readmissions. They delay recovery, increase pain sensitivity, impair cognition, and elevate cardiovascular risk. Vascular comorbidities such as hypertension, diabetes, and hyperlipidemia further worsen outcomes by increasing the likelihood of ischemic events, impaired wound healing, and respiratory instability. Understanding how physiologic, behavioral, and sleep-related variables interact to influence postoperative recovery is essential for designing early detection and prevention strategies.

Artificial intelligence (AI) has shown increasing promise in predicting clinical deterioration and identifying high-risk patients across multiple surgical fields. A recent systematic review of 26 studies demonstrated that AI-based models-including natural language processing, classical machine-learning algorithms, and deep learning methods-can accurately predict hospital readmissions following major surgery. However, most available datasets do not combine preoperative, intraoperative, postoperative, and continuous physiologic signals collected in real time from wearable devices, representing a major gap in the literature. This prospective cohort study aims to address this gap by integrating high-resolution physiologic and behavioral data captured from wearable devices-specifically smartwatches and smart rings-into a unified perioperative database, with the overarching goal of developing AI models capable of predicting unplanned hospital readmissions within 30 days after surgery.

The study seeks to build a comprehensive database of patients undergoing medium- to large-scale elective surgeries, capturing physiologic and behavioral data from wearables and multiparametric monitors during the pre- and post-operative periods, including continuous monitoring in the first 48 hours of intensive care when indicated. Data collection will include continuous wearable monitoring via a web-based interface developed by CETELI/UFAM, pre- and post-operative clinical assessments, laboratory tests, imaging studies, pulmonary function evaluations, polysomnography, and validated sleep questionnaires. The study will evaluate correlations between physiologic and sleep-related variables derived from smartwatches and smart rings and the risk of hospital readmission.

Additionally, the study will develop applications for smartwatch and smart ring use in perioperative data capture and employ machine learning approaches-including deep architectures such as causal convolutional networks and recurrent neural networks, as well as classical methods such as support vector machines and decision trees-to predict hospital readmissions. Associations between wearable-derived sleep parameters and 30-day readmission risk will be analyzed, pre- and post-operative sleep data will be correlated with polysomnography and questionnaire results, and sleep quality will be compared between preoperative and post-operative periods.

This research is conducted through a multidisciplinary collaboration between the Hospital Universitário Getúlio Vargas (HUGV-UFAM/Ebserh), and the Center for Research and Development in Electronic and Information Technology (CETELI/UFAM). CETELI will be responsible for developing the data-collection software, storage architecture, and predictive algorithms, while clinical oversight, recruitment, and protocol execution will be led by HUGV.

Beyond scientific relevance, this project has significant practical importance. In geographically complex regions such as the Amazon, continuous remote monitoring using wearable devices can enhance follow-up, reduce disparities in access to postoperative care, and enable earlier identification of complications. Integrating AI-based prediction models with hospital workflows may ultimately reduce costs, optimize patient flow, and improve the safety and quality of surgical care.

03

Conditions studied

  • Patient Readmission

Keywords

  • Hospital Readmission
  • Postoperative Complications
  • Artificial Intelligence
  • Machine Learning
  • Wearable Electronic Devices
  • Physiological Monitoring
  • Sleep Disorders
  • Surgical Procedures, Operative
  • Perioperative Care
  • Amazon Region
  • Predictive Modeling
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients scheduled for medium- and large-scale elective surgeries at the Hospital Universitário Getúlio Vargas, a tertiary referral center in Amazonas. Patients are initially evaluated at the affiliated outpatient clinic, Ambulatório Araújo Lima. Eligible individuals will be invited to participate during preoperative consultations with the attending surgeon, approximately 15 days before hospital admission. Study procedures, information delivery, and informed consent will be conducted by the surgical specialists responsible for outpatient care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults over 18 years of age;
  • Hospitalization for medium and/or large elective surgery at HUGV;
  • Conscious and oriented patients who have sufficient understanding to answer questionnaires and use wearable devices for the study;
  • Have minimal skills in the use of wearable technologies;
  • Patients who have agreed to participate voluntarily in the research by signing the Form (ICF).

Non-inclusion Criteria:

  • Presence of tattoos or any other skin condition (skin pathologies or skin diseases such as vitiligo, lupus, and atopic dermatitis, among others) that affects the area of the wrist or finger where the wearable sensors are located;
  • Presence of any type of sensitivity or allergic reaction, of any degree, to the materials of the wearables (smartwatch and smartring);
  • Pregnant and lactating women;
  • Participants with implantable cardiac devices, such as pacemakers, cardioverter defibrillators, and resynchronization devices;
  • Participants in drugs abuse;

Exclusion criteria

Exclusion Criteria:

  • Severe medical conditions and decompensations prior to surgery;
  • Patients who die before hospital discharge;
  • Patients with an expected postoperative hospital stay of more than 10 days.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. 30-day hospital readmission

    Occurrence of any unplanned hospital readmission within 30 days after discharge following medium- and large-scale surgical procedures. The outcome is binary (Yes/No).

    Time frame: Within 30 days post-surgery

Secondary outcomes

  1. Length of hospital stay

    Total number of days from hospital admission to discharge following the surgical procedure.

    Time frame: From hospital admission through hospital discharge, up to postoperative day 10

  2. Need for reoperation

    Any surgical reintervention required during hospitalization or within the 30-day post-operative period.

    Time frame: Up to 30 days after surgery

  3. Number of Participants With Surgical Site Infection

    Time frame: Up to 30 days post-surgery (or up to hospital discharge if earlier)

  4. 30-day mortality

    All-cause death occurring within 30 days after the surgical procedure.

    Time frame: Up to 30 days post-surgery

  5. Subjective Sleep Quality Assessed by the Pittsburgh Sleep Quality Index (PSQI) Total Score

    Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) total score, which ranges from 0 to 21, with higher scores indicating worse sleep quality.

    Time frame: Pre-operative baseline (2 days before admission) and post-operative follow-up at 14 days after hospital discharge.

  6. Insomnia Severity Assessed by the Insomnia Severity Index (ISI) Total Score

    Insomnia severity will be assessed using the Insomnia Severity Index (ISI) total score, which ranges from 0 to 28, with higher scores indicating more severe insomnia

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  7. Risk of Sleep-Disordered Breathing Assessed by the Neck, Obesity, Snoring, Age, Sex (NoSAS) Score

    Risk of sleep-disordered breathing will be assessed using the Neck, Obesity, Snoring, Age, Sex (NoSAS) score, which ranges from 0 to 17, with higher scores indicating a higher risk of sleep-disordered breathing.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  8. Daytime Sleepiness Assessed by the Epworth Sleepiness Scale (ESS) Total Score

    Daytime sleepiness will be assessed using the Epworth Sleepiness Scale (ESS) total score, which ranges from 0 to 24, with higher scores indicating greater daytime sleepiness.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  9. Total Sleep Time Assessed by Polysomnography

    Total sleep time measured in minutes using overnight polysomnography.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  10. Sleep Efficiency Assessed by Polysomnography

    Sleep efficiency measured as a percentage (%) using overnight polysomnography.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  11. Sleep Latency Assessed by Polysomnography

    Sleep latency measured in minutes using overnight polysomnography.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  12. Wake After Sleep Onset Assessed by Polysomnography

    Wake after sleep onset measured in minutes using overnight polysomnography.

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

  13. Apnea-Hypopnea Index Assessed by Polysomnography

    Apnea-Hypopnea Index (AHI), measured as the number of events per hour of sleep using overnight polysomnography. Higher values indicate more severe sleep-disordered breathing

    Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Iucif N Jr, Rocha JS. [Study of inequalities in hospital mortality using the Charlson comorbidity index]. Rev Saude Publica. 2004 Dec;38(6):780-6. doi: 10.1590/s0034-89102004000600005. Epub 2004 Dec 10. Portuguese. PubMed 15608895 ↗
  • Duarte RL, Magalhaes-da-Silveira FJ, Oliveira-E-Sa TS, Silva JA, Mello FC, Gozal D. Obstructive Sleep Apnea Screening with a 4-Item Instrument, Named GOAL Questionnaire: Development, Validation and Comparative Study with No-Apnea, STOP-Bang, and NoSAS. Nat Sci Sleep. 2020 Jan 23;12:57-67. doi: 10.2147/NSS.S238255. eCollection 2020. PubMed 32158294 ↗
  • Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Menna Barreto SS, Johns MW. Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol. 2009 Sep;35(9):877-83. doi: 10.1590/s1806-37132009000900009. English, Portuguese. PubMed 19820814 ↗
  • Yanagimori M, Fernandes MD, Grad GF, Monare AB, Garcia BMSP, Rosanelli I, Mariano PMMS, Drummond SPA, O'Driscoll DM, Edwards BA, Lorenzi-Filho G, Genta PR. Abbreviated versions of the insomnia severity index to screen for comorbid insomnia among obstructive sleep apnea patients. Sleep Med. 2025 Feb;126:19-24. doi: 10.1016/j.sleep.2024.11.035. Epub 2024 Nov 26. PubMed 39615273 ↗
  • Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, Miozzo IC, de Barba ME, Barreto SS. Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index. Sleep Med. 2011 Jan;12(1):70-5. doi: 10.1016/j.sleep.2010.04.020. Epub 2010 Dec 9. PubMed 21145786 ↗
  • Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012 Apr 26;4(4):90-102. doi: 10.4330/wjc.v4.i4.90. PubMed 22558488 ↗
  • Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res. 2013 Aug;47 Suppl 1:3-27. doi: 10.3109/10715762.2013.815348. PubMed 23767955 ↗
  • Atzeni IM, van de Zande SC, Westra J, Zwerver J, Smit AJ, Mulder DJ. The AGE Reader: A non-invasive method to assess long-term tissue damage. Methods. 2022 Jul;203:533-541. doi: 10.1016/j.ymeth.2021.02.016. Epub 2021 Feb 23. PubMed 33636313 ↗
  • Amorim RL, Oliveira LM, Malbouisson LM, Nagumo MM, Simoes M, Miranda L, Bor-Seng-Shu E, Beer-Furlan A, De Andrade AF, Rubiano AM, Teixeira MJ, Kolias AG, Paiva WS. Prediction of Early TBI Mortality Using a Machine Learning Approach in a LMIC Population. Front Neurol. 2020 Jan 24;10:1366. doi: 10.3389/fneur.2019.01366. eCollection 2019. PubMed 32038454 ↗
  • Hale AT, Stonko DP, Lim J, Guillamondegui OD, Shannon CN, Patel MB. Using an artificial neural network to predict traumatic brain injury. J Neurosurg Pediatr. 2019 Feb 1;23(2):219-226. doi: 10.3171/2018.8.PEDS18370. Epub 2018 Nov 2. PubMed 30485240 ↗
  • Fares MY, Liu HH, da Silva Etges APB, Zhang B, Warner JJP, Olson JJ, Fedorka CJ, Khan AZ, Best MJ, Kirsch JM, Simon JE, Sanders B, Costouros JG, Zhang X, Jones P, Haas DA, Abboud JA; Avant-Garde Health and Codman Society Value-Based Care Group. Utility of Machine Learning, Natural Language Processing, and Artificial Intelligence in Predicting Hospital Readmissions After Orthopaedic Surgery: A Systematic Review and Meta-Analysis. JBJS Rev. 2024 Aug 22;12(8). doi: 10.2106/JBJS.RVW.24.00075. eCollection 2024 Aug 1. PubMed 39172864 ↗
  • Shameer K, Johnson KW, Yahi A, Miotto R, Li LI, Ricks D, Jebakaran J, Kovatch P, Sengupta PP, Gelijns S, Moskovitz A, Darrow B, David DL, Kasarskis A, Tatonetti NP, Pinney S, Dudley JT. PREDICTIVE MODELING OF HOSPITAL READMISSION RATES USING ELECTRONIC MEDICAL RECORD-WIDE MACHINE LEARNING: A CASE-STUDY USING MOUNT SINAI HEART FAILURE COHORT. Pac Symp Biocomput. 2017;22:276-287. doi: 10.1142/9789813207813_0027. PubMed 27896982 ↗
  • Min X, Yu B, Wang F. Predictive Modeling of the Hospital Readmission Risk from Patients' Claims Data Using Machine Learning: A Case Study on COPD. Sci Rep. 2019 Feb 20;9(1):2362. doi: 10.1038/s41598-019-39071-y. PubMed 30787351 ↗
  • Majumder S, Mondal T, Deen MJ. Wearable Sensors for Remote Health Monitoring. Sensors (Basel). 2017 Jan 12;17(1):130. doi: 10.3390/s17010130. PubMed 28085085 ↗
  • Rumalla K, Srinivasan VM, Gaddis M, Kan P, Lawton MT, Burkhardt JK. Readmission following extracranial-intracranial bypass surgery in the United States: nationwide rates, causes, risk factors, and volume-driven outcomes. J Neurosurg. 2020 Nov 6;135(2):431-439. doi: 10.3171/2020.6.JNS202117. Print 2021 Aug 1. PubMed 33157529 ↗
  • Li Z, Armstrong EJ, Parker JP, Danielsen B, Romano PS. Hospital variation in readmission after coronary artery bypass surgery in California. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):729-37. doi: 10.1161/CIRCOUTCOMES.112.966945. Epub 2012 Sep 4. PubMed 22949489 ↗
  • Silva RAGE, Borgomoni GB, de Freitas FL, Maia ADS, Farias do Vale Junior C, Pereira EDS, Silvestre LGI, Dallan LRP, Lisboa LA, Dallan LAO, Jatene FB, Mejia OAV; grupo de estudos REPLICCAR. Predictors of 30-Day Hospital Readmission Following CABG in a Multicenter Database: A Cross-Sectional Study. Arq Bras Cardiol. 2024 Sep 6;121(9):e20230768. doi: 10.36660/abc.20230768. eCollection 2024. English, Portuguese. PubMed 39258643 ↗
  • Scalzitti NJ, O'Connor PD, Nielsen SW, Aden JK, Brock MS, Taylor DM, Mysliwiec V, Dion GR. Obstructive Sleep Apnea is an Independent Risk Factor for Hospital Readmission. J Clin Sleep Med. 2018 May 15;14(5):753-758. doi: 10.5664/jcsm.7098. PubMed 29734972 ↗
  • Lan T, Liao YH, Zhang J, Yang ZP, Xu GS, Zhu L, Fan DM. Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis. Ther Clin Risk Manag. 2021 Dec 7;17:1307-1320. doi: 10.2147/TCRM.S340587. eCollection 2021. PubMed 34908840 ↗
  • Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, Hernandez AF, Konstam MA, Yancy CW, O'Connor CM. The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper. JACC Heart Fail. 2020 Jan;8(1):1-11. doi: 10.1016/j.jchf.2019.07.012. Epub 2019 Oct 9. PubMed 31606360 ↗
  • Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009 Apr 2;360(14):1418-28. doi: 10.1056/NEJMsa0803563. PubMed 19339721 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 5 months is below that.

Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 2, 2025
First posted
Jan 20, 2026
StartActual
Mar 4, 2026
Primary completionEst.
Aug 2026
CompletionEst.
Jun 2028
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07349901
Lead sponsor
Getúlio Vargas University Hospital
Collaborators
Universidade Federal do Amazonas, Samsung Eletrônica da Amazônia Ltda
Responsible party
Sponsor
First posted
Jan 20, 2026
Start date
Mar 4, 2026
Primary completion
Aug 2026 (estimated)
Completion
Jun 2028 (estimated)
Last update
Mar 17, 2026

Study contacts

Robson Luís Oliveira de Amorim, PhD
Contact
robsonamorim@ufam.edu.br
+55 92 99403-4101
Maria Elizete de Almeida Araújo, Doctor of Health Science- DHSc
Contact
elizetemanaus@ufam.edu.br
+55 92 99114-3693
Maria Elizete de Almeida Araújo, Doctor of Health Science
study director · Getúlio Vargas University Hospital
Marly Guimarães Fernandes Costa
study director · Federal University of Amazonas
Robson Luís Oliveira de Amorim
principal investigator · Getúlio Vargas University Hospital
Caio Eduardo Rodrigues Falcão
study chair · Getúlio Vargas University Hospital
Cícero Ferreira Fernandes Costa Filho
study chair · Federal University of Amazonas
José Corrêa Lima Netto
study chair · Getúlio Vargas University Hospital
Francisco de Assis Pereira Januário
study chair · Federal University of Amazonas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion